BIOMAT Database Logo BIOMAT Database Logo

[Clinical study of medazepam (Ro-5-45556)]. 1970

L Gayral, and H Fournié

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011602 Psychophysiologic Disorders A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988) Psychosomatic Disorders,Psychophysiological Disorders,Psychophysiologic Disorder,Psychophysiological Disorder,Psychosomatic Disorder
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

L Gayral, and H Fournié
Some observations on the neuropharmacology of medazepam hydrochloride (Ro 5-4556).
May 1970, Archives internationales de pharmacodynamie et de therapie,
L Gayral, and H Fournié
[Clinical study on various indications of flunitrazepam (Ro 5-42008 Ro-hypnol)].
May 1977, Revista espanola de anestesiologia y reanimacion,
L Gayral, and H Fournié
[CLINICAL RESEARCH OF RO-5-2807].
March 1964, Anales de medicina: Especialidades,
L Gayral, and H Fournié
[Clinical study of RO-5-4023 in the treatment of epilepsy].
March 1973, Arquivos de neuro-psiquiatria,
L Gayral, and H Fournié
Proceedings: Medazepam, oxazepam and placebo--clinical and experimental study.
January 1975, Activitas nervosa superior,
L Gayral, and H Fournié
[CLINICAL EXPERIMENTATION WITH RO 4-3816/5].
November 1963, Cahiers d'anesthesiologie,
L Gayral, and H Fournié
Clinical experience with Ro 5-3350 (bromazepam).
January 1975, The Journal of international medical research,
L Gayral, and H Fournié
[Clinical experiences with librium (Ro 5-0690)].
September 1960, Praxis,
L Gayral, and H Fournié
[Clinical use of medazepam in neuropsychiatry].
November 1974, La Clinica terapeutica,
L Gayral, and H Fournié
A clinical trial with clonazepam (Ro 5-4023).
January 1973, Acta neurologica Scandinavica. Supplementum,
Copied contents to your clipboard!